With the support of the Cell and Gene Therapy Catapult and the Advanced Therapy Treatment Centres (ATTC) Network, Genetic Alliance UK and EuroGCT joined forces in March 2022 to progress our understanding of the information needs of people living with rare conditions who wish to engage with gene and cell therapy progress.